Quote:
Originally Posted by John41
The US already had enough vaccine to vaccinate the most vulnerable by the target date of the end of 2020. That was the goal. So it shared the excess with Europe just as it did with the extra ventilators the US produced.
|
As of last summer, it seemed likely the developed-in-Germany-Pfizer-to-be-distributed vaccine would LIKELY (?) be the 1st available to the US vaccine. The US also had 4 or 5 other US manufacturers with a vaccine, including J and J. The US leadership, apparently, wanted to diversify its sponsorship bets. But, it still, looking back, may have been a mistake to not put Pfizer under additional US contracts rather than allow Europe to outflank us and buy up Pfizer's 2nd batch. The whole 1st world was, and still is, in a bidding war for CV vaccine, even Canada has bid for many doses of ALL upcoming vaccines. The 3rd world is out of luck for a while - until less expensive vaccines are available.
Unfortunately, in a Global economy, there can be CV spread from 3rd world to 1st and back again.